Untargeted serum metabolomic profiles and breast density in young women.

[1]  M. Kazanietz,et al.  Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity , 2022, Science Signaling.

[2]  E. Bairaktari,et al.  The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology , 2022, International journal of molecular sciences.

[3]  P. Lundberg,et al.  Breast Density and Estradiol Are Major Determinants for Soluble TNF-TNF-R Proteins in vivo in Human Breast Tissue , 2022, Frontiers in Immunology.

[4]  L. Larsson,et al.  Metabolomic Profiling of Respiratory Muscles and Lung in Response to Long-Term Controlled Mechanical Ventilation , 2022, Frontiers in Cell and Developmental Biology.

[5]  V. Viallon,et al.  Biomarkers of mammographic density in premenopausal women , 2021, Breast cancer research : BCR.

[6]  C. Luchinat,et al.  Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density , 2021, Scientific Reports.

[7]  C. Clish,et al.  Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women , 2021, NPJ breast cancer.

[8]  L. Larsson,et al.  Multi-omics reveals age-related differences in the diaphragm response to mechanical ventilation: a pilot study , 2021, Skeletal muscle.

[9]  G. Severi,et al.  Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case–control study nested within the French E3N cohort , 2021, British Journal of Cancer.

[10]  C. Matthews,et al.  A Metabolomics Analysis of Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II , 2021, Metabolites.

[11]  J. Manson,et al.  Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women , 2020, Scientific Reports.

[12]  Yoosoo Chang,et al.  Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women , 2020, Cancer.

[13]  Jacob E. Wulff,et al.  Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism. , 2020, The journal of applied laboratory medicine.

[14]  M. Zhan,et al.  Alcohol consumption and serum metabolite concentrations in young women , 2019, Cancer Causes & Control.

[15]  V. Viallon,et al.  Prospective analysis of circulating metabolites and breast cancer in EPIC , 2019, BMC Medicine.

[16]  C. Kaya,et al.  The Relation Between Metabolic Syndrome and Its Components with Breast Density in Postmenopausal Women. , 2019, Metabolic syndrome and related disorders.

[17]  David A. Hughes,et al.  Assessment of reproducibility and biological variability of fasting and postprandial plasma metabolite concentrations using 1H NMR spectroscopy , 2019, PloS one.

[18]  G. Maskarinec,et al.  Mammographic density and breast tissue expression of inflammatory markers, growth factors, and vimentin , 2018, BMC Cancer.

[19]  E. Thompson,et al.  High mammographic density in women is associated with protumor inflammation , 2018, Breast Cancer Research.

[20]  Sun Ha Jee,et al.  Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II , 2018, Metabolomics.

[21]  R. Hoover,et al.  Nutritional metabolomics and breast cancer risk in a prospective study. , 2017, The American journal of clinical nutrition.

[22]  Ling Zhang,et al.  Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function. , 2017, Biochemical and biophysical research communications.

[23]  J. Quiles,et al.  A plasma metabolomic signature discloses human breast cancer , 2017, Oncotarget.

[24]  H. Boeing,et al.  Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study , 2016, BMC Medicine.

[25]  Yoosoo Chang,et al.  Metabolic syndrome, insulin resistance, and mammographic density in pre- and postmenopausal women , 2015, Breast Cancer Research and Treatment.

[26]  A. Protacio,et al.  The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women , 2015, Cancer Causes & Control.

[27]  T. Eichmann,et al.  DAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling , 2015, Cellular and Molecular Life Sciences.

[28]  I. Mérida,et al.  Redundant and specialized roles for diacylglycerol kinases α and ζ in the control of T cell functions , 2015, Science Signaling.

[29]  Alla Karnovsky,et al.  Metabolomics and Diabetes: Analytical and Computational Approaches , 2015, Diabetes.

[30]  D. Harvey,et al.  Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort , 2015, Cancer Causes & Control.

[31]  C. Vachon,et al.  Mammographic density phenotypes and risk of breast cancer: a meta-analysis. , 2014, Journal of the National Cancer Institute.

[32]  R. Sinha,et al.  Human metabolic correlates of body mass index , 2014, Metabolomics.

[33]  Song Liu,et al.  Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. , 2013, Translational oncology.

[34]  Peter Kraft,et al.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. , 2013, Clinical chemistry.

[35]  L. Akslen,et al.  Variation in Inflammatory Cytokine/Growth-Factor Genes and Mammographic Density in Premenopausal Women Aged 50–55 , 2013, PloS one.

[36]  Catherine Klifa,et al.  Height, adiposity and body fat distribution and breast density in young women , 2012, Breast Cancer Research.

[37]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[38]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[39]  D. Harvey,et al.  Metabolic syndrome and mammographic density: The Study of Women's Health Across the Nation , 2011, International journal of cancer.

[40]  J. Weissfeld,et al.  Circulating levels of inflammatory markers and mammographic density among postmenopausal women , 2011, Breast Cancer Research and Treatment.

[41]  V. McCormack,et al.  Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2010, International journal of cancer.

[42]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[43]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[44]  D. Miglioretti,et al.  Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.

[45]  V. Stevens,et al.  Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). , 2001, Pediatrics.

[46]  V. Stevens,et al.  Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). , 1997, Pediatrics.

[47]  Ncep Expert Panel on Blood Cholesterol Levels in Childr Adolescents.  National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. , 1992, Pediatrics.

[48]  OUP accepted manuscript , 2021, Journal of NutriLife.

[49]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[50]  N. Boyd,et al.  Associations between mammographic density and serum and dietary cholesterol , 2010, Breast Cancer Research and Treatment.

[51]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.